CFM
MENS

Cornerstone Financial Management’s Jyong Biotech MENS Stock Holding History

Cornerstone Financial Management’s Portfolio MENS Stock Details MENS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$484 Buy
+234
New +$496 ﹤0.01% 1406
2026
Q1 		– Sell
-14
Closed -$55 – 1400
2025
Q4 		$55 Buy
+14
New +$494 ﹤0.01% 1236

Other funds holding MENS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
SOW
State of Wyoming Cheyenne, Wyoming $989M AUM 52.24% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Cornerstone Financial Management's MENS Position: Q2 2026 in Review

Cornerstone Financial Management opened a new position in Jyong Biotech (MENS) in Q2 2026: 234 shares worth $484. The stake represents ﹤0.01% of the portfolio and ranks #1406 among its holdings. This is a return to the name: Cornerstone Financial Management previously reported a position in MENS as recently as Q4 2025.

Cornerstone Financial Management first reported a position in MENS in Q4 2025 and has held it in 2 quarters since. 19 funds tracked by Wall St. Rank hold MENS as of Q2 2026.

  • Cornerstone Financial Management held 234 shares of Jyong Biotech worth $484 as of Q2 2026.
  • Jyong Biotech was a new Cornerstone Financial Management position in Q2 2026.
  • Jyong Biotech made up ﹤0.01% of Cornerstone Financial Management's portfolio in Q2 2026, its #1406 holding.
  • Cornerstone Financial Management first reported a position in Jyong Biotech in Q4 2025 and has held it in 2 quarters since.
  • 19 funds tracked by Wall St. Rank held Jyong Biotech as of Q2 2026.

Based on Cornerstone Financial Management's 13F filing for Q2 2026, filed 12 Aug 2026.